1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/23117
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-12-09T08:01:59Z-
dc.date.available2021-12-09T08:01:59Z-
dc.date.issued2009-08-
dc.identifier.citationŞentürk, T. vd. (2009). "Capecitabine-induced cardiotoxicity mimicking myocardial infarction". Netherlands Heart Journal, 17(7-8), 277-280.en_US
dc.identifier.issn1568-5888-
dc.identifier.urihttps://doi.org/10.1007/BF03086265-
dc.identifier.urihttps://link.springer.com/article/10.1007%2FBF03086265-
dc.identifier.urihttp://hdl.handle.net/11452/23117-
dc.description.abstractCapecitabine, a fluoropyrimidine derivative, is an orally administered drug that delivers 5-fluorouracil (5-FU) selectively to the tumour. The drug has demonstrated activity in metastatic colorectal cancer. We describe a male patient receiving capecitabine therapy with typical chest pain and electrocardiographic changes consistent with ST-segment elevation myocardial infarction. Capecitabine-induced cardiotoxicity may develop in patients who have had a previous episode of 5-FU-induced cardiotoxicity. Capecitabine-induced cardiotoxicity is a rare condition that may lead to diagnostic and therapeutic dilemmas.en_US
dc.language.isoenen_US
dc.publisherBohn Stafleu van Loghumen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCapecitabineen_US
dc.subjectCardiotoxicityen_US
dc.subjectMyocardial infarctionen_US
dc.subjectCardiovascular system & cardiologyen_US
dc.titleCapecitabine-induced cardiotoxicity mimicking myocardial infarctionen_US
dc.typeArticleen_US
dc.identifier.wos000269178900004tr_TR
dc.identifier.scopus2-s2.0-70349283313tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-8974-8837tr_TR
dc.identifier.startpage277tr_TR
dc.identifier.endpage280tr_TR
dc.identifier.volume17tr_TR
dc.identifier.issue7-8tr_TR
dc.relation.journalNetherlands Heart Journalen_US
dc.contributor.buuauthorŞentürk, Tunay-
dc.contributor.buuauthorKanat, Özkan-
dc.contributor.buuauthorEvrensel, Türkkan-
dc.contributor.buuauthorAydınlar, Ali-
dc.contributor.researcheridC-1517-2017tr_TR
dc.contributor.researcheridAAI-6632-2021tr_TR
dc.identifier.pubmed19789694tr_TR
dc.subject.wosCardiac & cardiovascular systemsen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid8342098300tr_TR
dc.contributor.scopusid55881548500tr_TR
dc.contributor.scopusid6603942124tr_TR
dc.contributor.scopusid6603131517tr_TR
dc.subject.scopusCapecitabine; Cardiotoxicity; Coronary Artery Spasmen_US
dc.subject.emtreeCapecitabineen_US
dc.subject.emtreeDiltiazemen_US
dc.subject.emtreeFluorouracilen_US
dc.subject.emtreeFolinic aciden_US
dc.subject.emtreeIsosorbide mononitrateen_US
dc.subject.emtreeOxaliplatinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCancer adjuvant therapyen_US
dc.subject.emtreeCardiotoxicityen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeContinuous infusionen_US
dc.subject.emtreeDifferential diagnosisen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeHeart infarctionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeRectum carcinomaen_US
dc.subject.emtreeST segment elevationen_US
dc.subject.emtreeSymptomen_US
dc.subject.emtreeThorax painen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Şentürk_vd_2009.pdf330.93 kBAdobe PDFThumbnail
View/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons